Inflammatory bowel diseases: interrelationships between dietary vitamin D, exposure to UV radiation and the fecal microbiome

References

• Wallace KL, Zheng LB, Kanazawa Y, et al. Immunopathology of inflammatory bowel disease. World J Gastroenterol. 2014;20(1):6–21.
   PubMed Web of Science ®Google Scholar
• Khalili H, Huang ES, Ananthakrishnan AN, et al. Geographical variation and incidence of inflammatory bowel disease among US women. Gut. 2012;61(12):1686–1692.
   PubMed Web of Science ®Google Scholar
• Gearry RB, Richardson A, Frampton CM, et al. High incidence of Crohn’s disease in Canterbury, New Zealand: results of an epidemiologic study. Inflamm Bowel Dis. 2006;12(10):936–943.
   PubMed Web of Science ®Google Scholar
• Loftus EV. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126(6):1504–1517.
   PubMed Web of Science ®Google Scholar
• Shivananda S, Lennard-Jones J, Logan R, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut. 1996;39(5):690–697.
   PubMed Web of Science ®Google Scholar
• Gower-Rousseau C, Salomez JL, Dupas JL, et al. Incidence of inflammatory bowel disease in northern France (1988–1990). Gut. 1994;35(10):1433–1438.
   PubMed Web of Science ®Google Scholar
• Sonnenberg A. Demographic characteristics of hospitalized IBD patients. Dig Dis Sci. 2009;54(11):2449–2455.
   PubMed Web of Science ®Google Scholar
• Nerich V, Monnet E, Etienne A, et al. Geographical variations of inflammatory bowel disease in France: a study based on national health insurance data. Inflamm Bowel Dis. 2006;12(3):218–226.
   PubMed Web of Science ®Google Scholar
• Jantchou P, Clavel-Chapelon F, Racine A, et al. High residential sun exposure is associated with a low risk of incident Crohn’s disease in the prospective E3N Cohort. Inflamm Bowel Dis. 2013;20:75–81.
   Web of Science ®Google Scholar
• Nerich V, Jantchou P, Boutron-Ruault M-C, et al. Low exposure to sunlight is a risk factor for Crohn’s disease. Aliment Pharmacol Ther. 2011;33(8):940–945.
   PubMed Web of Science ®Google Scholar
• Ghaly S, Lawrance I. The role of vitamin D in gastrointestinal inflammation. Expert Rev Gastroenterol Hepatol. 2014;8:1–15.
   PubMed Web of Science ®Google Scholar
• Hart PH, Norval M, Byrne SN, et al. Exposure to ultraviolet radiation in the modulation of human diseases. Annu Rev Pathol. 2019;14:55–81.
   PubMed Web of Science ®Google Scholar
• Ananthakrishnan AN, Khalili H, Higuchi LM, et al. Higher predicted vitamin D status is associated with reduced risk of Crohn’s disease. Gastroenterology. 2012;142(3):482–489.
   PubMed Web of Science ®Google Scholar
• Jørgensen SP, Hvas CL, Agnholt J, et al. Active Crohn’s disease is associated with low vitamin D levels. J Crohns Colitis. 2013;7(10):e407–e413.
   PubMedGoogle Scholar
• Ulitsky A, Ananthakrishnan AN, Naik A, et al. Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. JPEN J Parenter Enteral Nutr. 2011;35(3):308–316.
   PubMed Web of Science ®Google Scholar
• Harries AD, Brown R, Heatley RV, et al. Vitamin D status in Crohn’s disease: association with nutrition and disease activity. Gut. 1985;26(11):1197–1203.
   PubMed Web of Science ®Google Scholar
• Ananthakrishnan AN, Cagan A, Gainer VS, et al. Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn’s disease. Inflamm Bowel Dis. 2013;19:1.
   Web of Science ®Google Scholar
• Ananthakrishnan AN, Cheng S-C, Cai T, et al. Association between reduced plasma 25-hydroxy vitamin D and increased risk of cancer in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2013;12:821–827.
   PubMed Web of Science ®Google Scholar
• Ahuja V, Tandon RK. Inflammatory bowel disease in the Asia-Pacific area: a comparison with developed countries and regional differences. J Dig Dis. 2010;11(3):134–147.
   PubMed Web of Science ®Google Scholar
• Ng WK, Wong SH, Ng SC. Changing epidemiological trends of inflammatory bowel disease in Asia. Intest Res. 2016;14(2):111–119.
   PubMed Web of Science ®Google Scholar
• McIlroy J, Ianiro G, Mukhopadhya I, et al. Review article: the gut microbiome in inflammatory bowel disease-avenues for microbial management. Aliment Pharmacol Ther. 2018;47(1):26–42.
   PubMed Web of Science ®Google Scholar
• Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464(7285):59–65.
   PubMed Web of Science ®Google Scholar
• Murphy K, Travers P, Walport M, et al. Janeway’s immunobiology. New York (NY): Garland Science; 2012.
   Google Scholar
• Kahrstrom CT, Pariente N, Weiss U. Intestinal microbiota in health and disease. Nature. 2016;535(7610):47.
   PubMed Web of Science ®Google Scholar
• Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology. 2014;146:1489–1499.
   PubMed Web of Science ®Google Scholar
• Forbes JD, Van Domselaar G, Bernstein CN. Microbiome survey of the inflamed and noninflamed gut at different compartments within the gastrointestinal tract of inflammatory bowel disease patients. Inflamm Bowel Dis. 2016;22(4):817–825.
   PubMed Web of Science ®Google Scholar
• Khan KJ, Ullman TA, Ford AC, et al. Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol. 2011;106(4):661–673.
   PubMed Web of Science ®Google Scholar
• Harper PH, Lee EC, Kettlewell MG, et al. Role of the faecal stream in the maintenance of Crohn’s colitis. Gut. 1985;26(3):279–284.
   PubMed Web of Science ®Google Scholar
• Rutgeerts P, Goboes K, Peeters M, et al. Effect of faecal stream diversion on recurrence of Crohn’s disease in the neoterminal ileum. Lancet. 1991;338(8770):771–774.
   PubMed Web of Science ®Google Scholar
• Janowitz HD, Croen EC, Sachar DB. The role of the fecal stream in Crohn’s disease: an historical and analytic review. Inflamm Bowel Dis. 1998;4(1):29–39.
   PubMed Web of Science ®Google Scholar
• Paramsothy S, Kamm MA, Kaakoush NO, et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet. 2017;389(10075):1218–1228.
   PubMed Web of Science ®Google Scholar
• Moayyedi P, Surette MG, Kim PT, et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology. 2015;149(1):102–109 e106.
   PubMed Web of Science ®Google Scholar
• Costello SP, Hughes PA, Waters O, et al. Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial. JAMA. 2019;321(2):156–164.
   PubMed Web of Science ®Google Scholar
• Manichanh C, Rigottier-Gois L, Bonnaud E, et al. Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach. Gut. 2006;55(2):205–211.
   PubMed Web of Science ®Google Scholar
• Walker AW, Sanderson JD, Churcher C, et al. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol. 2011;11:7.
   PubMed Web of Science ®Google Scholar
• Swidsinski A, Weber J, Loening-Baucke V, et al. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol. 2005;43(7):3380–3389.
   PubMed Web of Science ®Google Scholar
• Pascal V, Pozuelo M, Borruel N, et al. A microbial signature for Crohn’s disease. Gut. 2017;66(5):813–822.
   PubMed Web of Science ®Google Scholar
• Hansen R, Russell RK, Reiff C, et al. Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn’s but not in ulcerative colitis. Am J Gastroenterol. 2012;107(12):1913–1922.
   PubMed Web of Science ®Google Scholar
• Lopez-Siles M, Khan TM, Duncan SH, et al. Cultured representatives of two major phylogroups of human colonic Faecalibacterium prausnitzii can utilize pectin, uronic acids, and host-derived substrates for growth. Appl Environ Microbiol. 2012;78(2):420–428.
   PubMed Web of Science ®Google Scholar
• Barnich N, Denizot J, Darfeuille-Michaud AE. coli-mediated gut inflammation in genetically predisposed Crohn’s disease patients. Pathol Biol. 2013;61(5):e65–e69.
   PubMedGoogle Scholar
• Shaw KA, Bertha M, Hofmekler T, et al. Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease. Genome Med. 2016;8(1):75.
   PubMedGoogle Scholar
• Ghaly S, Kaakoush NO, Lloyd F, et al. High dose vitamin D supplementation alters faecal microbiome and predisposes mice to more severe colitis. Sci Rep. 2018;8(1):11511.
   PubMedGoogle Scholar
• Schirmer M, Franzosa EA, Lloyd-Price J, et al. Dynamics of metatranscription in the inflammatory bowel disease gut microbiome. Nat Microbiol. 2018;3(3):337–346.
   PubMed Web of Science ®Google Scholar
• Gevers D, Kugathasan S, Knights D, et al. A microbiome foundation for the study of Crohn’s disease. Cell Host Microbe. 2017;21(3):301–304.
   PubMed Web of Science ®Google Scholar
• Suskind DL, Cohen SA, Brittnacher MJ, et al. Clinical and fecal microbial changes with diet therapy in active inflammatory bowel disease. J Clin Gastroenterol. 2018;52(2):155–163.
   PubMed Web of Science ®Google Scholar
• Ananthakrishnan AN, Luo C, Yajnik V, et al. Gut microbiome function predicts response to anti-integrin biologic therapy in inflammatory bowel diseases. Cell Host Microbe. 2017;21(5):603–610 e603.
   PubMed Web of Science ®Google Scholar
• Ghaly S, Lawrance I. The role of vitamin D in gastrointestinal inflammation. Expert Rev Gastroenterol Hepatol. 2014;8(8):909–923.
   PubMed Web of Science ®Google Scholar
• Zhang Y-G, Wu S, Sun J. Vitamin D, vitamin D receptor, and tissue barriers. Tissue Barriers. 2013;1(1):e23118.
   PubMedGoogle Scholar
• Kong J, Zhang Z, Musch MW, et al. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol. 2008;294(1):G208–G216.
   PubMed Web of Science ®Google Scholar
• Zaiou M, Gallo RL. Cathelicidins, essential gene-encoded mammalian antibiotics. J Mol Med (Berl). 2002;80(9):549–561.
   PubMed Web of Science ®Google Scholar
• Penna G, Adorini L. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Iimmunol. 2000;164(5):2405–2411.
   PubMed Web of Science ®Google Scholar
• Hewison M, Freeman L, Hughes SV, et al. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Iimmunol. 2003;170(11):5382–5390.
   PubMed Web of Science ®Google Scholar
• Bhalla AK, Amento EP, Clemens TL, et al. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab. 1983;57(6):1308–1310.
   PubMed Web of Science ®Google Scholar
• Provvedini DM, Manolagas SC. 1 Alpha,25-dihydroxyvitamin D3 receptor distribution and effects in subpopulations of normal human T lymphocytes. J Clin Endocrinol Metab. 1989;68(4):774–779.
   PubMed Web of Science ®Google Scholar
• Waterhouse M, Hope B, Krause L, et al. Vitamin D and the gut microbiome: a systematic review of in vivo studies. Eur J Nutr. 2018;58:2895–2910.
   PubMed Web of Science ®Google Scholar
• Lagishetty V, Misharin AV, Liu NQ, et al. Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis. Endocrinology. 2010;151(6):2423–2432.
   PubMed Web of Science ®Google Scholar
• Assa A, Vong L, Pinnell LJ, et al. Vitamin D deficiency promotes epithelial barrier dysfunction and intestinal inflammation. J Infect Dis. 2014;210(8):1296–1305.
   PubMed Web of Science ®Google Scholar
• Ooi JH, Li Y, Rogers CJ, et al. Vitamin D regulates the gut microbiome and protects mice from dextran sodium sulfate-induced colitis. J Nutr. 2013;143(10):1679–1686.
   PubMed Web of Science ®Google Scholar
• Wu S, Zhang YG, Lu R, et al. Intestinal epithelial vitamin D receptor deletion leads to defective autophagy in colitis. Gut. 2015;64(7):1082–1094.
   PubMed Web of Science ®Google Scholar
• Santoru ML, Piras C, Murgia A, et al. Cross sectional evaluation of the gut-microbiome metabolome axis in an Italian cohort of IBD patients. Sci Rep. 2017;7(1):9523.
   PubMedGoogle Scholar
• Schaffler H, Herlemann DP, Klinitzke P, et al. Vitamin D administration leads to a shift of the intestinal bacterial composition in Crohn’s disease patients, but not in healthy controls. J Dig Dis. 2018;19(4):225–234.
   PubMed Web of Science ®Google Scholar
• Garg M, Hendy P, Ding JN, et al. The effect of vitamin D on intestinal inflammation and faecal microbiota in patients with ulcerative colitis. J Crohns Colitis. 2018;12(8):963–972.
   PubMed Web of Science ®Google Scholar
• Bashir M, Prietl B, Tauschmann M, et al. Effects of high doses of vitamin D3 on mucosa-associated gut microbiome vary between regions of the human gastrointestinal tract. Eur J Nutr. 2015;55:1479–1489.
   PubMed Web of Science ®Google Scholar
• Kanhere M, He J, Chassaing B, et al. Bolus weekly vitamin D3 supplementation impacts gut and airway microbiota in adults with cystic fibrosis: a double-blind, randomized, placebo-controlled clinical trial. J Clin Endocrinol Metab. 2018;103(2):564–574.
   PubMed Web of Science ®Google Scholar
• Hollams EM, Teo SM, Kusel M, et al. Vitamin D over the first decade and susceptibility to childhood allergy and asthma. J Allergy Clin Immunol. 2017;139(2):472–481 e479.
   PubMed Web of Science ®Google Scholar
• Roggenbuck M, Anderson D, Barfod KK, et al. Vitamin D and allergic airway disease shape the murine lung microbiome in a sex-specific manner. Respir Res. 2016;17(1):116.
   PubMedGoogle Scholar
• Bodnar LM, Krohn MA, Simhan HN. Maternal vitamin D deficiency is associated with bacterial vaginosis in the first trimester of pregnancy. J Nutr. 2009;139(6):1157–1161.
   PubMed Web of Science ®Google Scholar
• Cahill KC, Conroy FJ, Brown A, et al. Tuberculous dactylitis in the setting of low serum vitamin D: a case report. J Plast Reconstr Aesthet Surg. 2011;64(12):e321–e324.
   PubMed Web of Science ®Google Scholar
• Jefferson KK, Parikh HI, Garcia EM, et al. Relationship between vitamin D status and the vaginal microbiome during pregnancy. J Perinatol. 2019;39(6):824–836.
   PubMed Web of Science ®Google Scholar
• Bora SA, Kennett MJ, Smith PB, et al. Regulation of vitamin D metabolism following disruption of the microbiota using broad spectrum antibiotics. J Nutr Biochem. 2018;56:65–73.
   PubMed Web of Science ®Google Scholar
• Bora SA, Kennett MJ, Smith PB, et al. The gut microbiota regulates endocrine vitamin D metabolism through fibroblast growth factor 23. Front Immunol. 2018;9:408.
   PubMed Web of Science ®Google Scholar
• Lin YD, Arora J, Diehl K, et al. Vitamin D is required for ILC3 derived IL-22 and protection from citrobacter rodentium infection. Front Immunol. 2019;10:1.
   PubMed Web of Science ®Google Scholar
• Jantchou P, Clavel-Chapelon F, Racine A, et al. High residential sun exposure is associated with a low risk of incident Crohn’s disease in the prospective E3N cohort. Inflamm Bowel Dis. 2014;20(1):75–81.
   PubMed Web of Science ®Google Scholar
• Limketkai BN, Bayless TM, Brant SR, et al. Lower regional and temporal ultraviolet exposure is associated with increased rates and severity of inflammatory bowel disease hospitalisation. Aliment Pharmacol Ther. 2014;40(5):508–517.
   PubMed Web of Science ®Google Scholar
• Gorman S, Scott NM, Tan DHW, et al. Acute erythemal ultraviolet radiation causes systemic immunosuppression in the absence of increased 25-hydroxyvitamin D3 levels in male mice. PLoS One. 2012;7(9):e46006.
   PubMed Web of Science ®Google Scholar
• Hart PH, Gorman S, Finlay-Jones JJ. Modulation of the immune system by UV radiation: more than just the effects of vitamin D? Nat Rev Immunol. 2011;11(9):584–596.
   PubMed Web of Science ®Google Scholar
• Bernard JJ, Cowing-Zitron C, Nakatsuji T, et al. Ultraviolet radiation damages self noncoding RNA and is detected by TLR3. Nat Med. 2012;18(8):1286–1290.
   PubMed Web of Science ®Google Scholar
• Hart PH, Norval M. Ultraviolet radiation-induced immunosuppression and its relevance for skin carcinogenesis. Photochem Photobiol Sci. 2018;17(12):1872–1884.
   PubMed Web of Science ®Google Scholar
• Suwanpradid J, Holcomb ZE, MacLeod AS. Emerging skin T-cell functions in response to environmental insults. J Invest Dermatol. 2017;137(2):288–294.
   PubMed Web of Science ®Google Scholar
• Holliman G, Lowe D, Cohen H, et al. Ultraviolet radiation-induced production of nitric oxide: amulti-cell and multi-donor analysis. Sci Rep. 2017;7(1):11105.
   PubMedGoogle Scholar
• Soontrapa K, Honda T, Sakata D, et al. Prostaglandin E2-prostaglandin E receptor subtype 4 (EP4) signaling mediates UV irradiation-induced systemic immunosuppression. Proc Natl Acad Sci USA. 2011;108(16):6668–6673.
   PubMed Web of Science ®Google Scholar
• Sheibanie AF, Yen J-H, Khayrullina T, et al. The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23–>IL-17 axis. J Iimmunol. 2007;178(12):8138–8147.
   PubMed Web of Science ®Google Scholar
• Baird AC, Lloyd F, Lawrance IC. Prostaglandin E(2) and polyenylphosphatidylcholine protect against intestinal fibrosis and regulate myofibroblast function. Dig Dis Sci. 2015;60(6):1603–1616.
   PubMed Web of Science ®Google Scholar
• Romano M, Machnicki G, Rojas JI, et al. There is much to be learnt about the costs of multiple sclerosis in Latin America. Arq Neuropsiquiatr. 2013;71(8):549–555.
   PubMed Web of Science ®Google Scholar
• Veldhoen M, Duarte JH. The aryl hydrocarbon receptor: fine-tuning the immune-response. Curr Opin Immunol. 2010;22(6):747–752.
   PubMed Web of Science ®Google Scholar
• Hiratsuka T, Inomata M, Goto S, et al. Phototherapy with artificial light suppresses dextran sulfate sodium-induced colitis in a mouse model. J Gastroenterol Hepatol. 2014;29(4):749–756.
   PubMed Web of Science ®Google Scholar
• Breuer J, Schwab N, Schneider-Hohendorf T, et al. Ultraviolet B light attenuates the systemic immune response in central nervous system autoimmunity. Ann Neurol. 2014;75(5):739–758.
   PubMed Web of Science ®Google Scholar
• Hiramoto K, Yamate Y, Sato EF. The effects of ultraviolet eye irradiation on dextran sodium sulfate-induced ulcerative colitis in mice. Photochem Photobiol. 2016;92(5):728–734.
   PubMed Web of Science ®Google Scholar
• Ghaly S, Kaakoush NO, Lloyd F, et al. Ultraviolet irradiation of skin alters the faecal microbiome independently of vitamin D in mice. Nutrients. 2018;10(8):1069.
   PubMed Web of Science ®Google Scholar
• Jeevan A, Evans R, Brown EL, et al. Effect of local ultraviolet irradiation on infections of mice with Candida albicans, mycobacterium bovis BCG, and schistosoma mansoni. J Invest Dermatol. 1992;99(1):59–64.
   PubMed Web of Science ®Google Scholar
• Cestari TF, Kripke ML, Baptista PL, et al. Ultraviolet radiation decreases the granulomatous response to lepromin in humans. J Invest Dermatol. 1995;105(1):8–13.
   PubMed Web of Science ®Google Scholar
• Brown EL, Ullrich SE, Pride M, et al. The effect of UV irradiation on infection of mice with Borrelia burgdorferi. Photochem Photobiol. 2001;73(5):537–544.
   PubMed Web of Science ®Google Scholar
• Glaser R, Navid F, Schuller W, et al. UV-B radiation induces the expression of antimicrobial peptides in human keratinocytes in vitro and in vivo. J Allergy Clin Immunol. 2009;123(5):1117–1123.
   PubMed Web of Science ®Google Scholar
• Burns EM, Ahmed H, Isedeh PN, et al. Ultraviolet radiation, both UVA and UVB, influences the composition of the skin microbiome. Exp Dermatol. 2019;28(2):136–141.
   PubMed Web of Science ®Google Scholar
• Sanford JA, Gallo RL. Functions of the skin microbiota in health and disease. Semin Immunol. 2013;25(5):370–377.
   PubMed Web of Science ®Google Scholar
• Kabbani TA, Koutroubakis IE, Schoen RE, et al. Association of vitamin D level with clinical status in inflammatory bowel disease: a 5-year longitudinal study. Am J Gastroenterol. 2016;111(5):712–719.
   PubMed Web of Science ®Google Scholar
• Ananthakrishnan AN, Cagan A, Gainer VS, et al. Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn’s disease. Inflamm Bowel Dis. 2013;19(9):1921–1927.
   PubMed Web of Science ®Google Scholar
• Opstelten JL, Chan SSM, Hart AR, et al. Prediagnostic serum vitamin D levels and the risk of Crohn’s disease and ulcerative colitis in European populations: a nested case-control study. Inflamm Bowel Dis. 2018;24(3):633–640.
   PubMed Web of Science ®Google Scholar
• Gubatan J, Mitsuhashi S, Zenlea T, et al. Low serum vitamin D during remission increases risk of clinical relapse in patients with ulcerative colitis. Clin Gastroenterol Hepatol. 2017;15(2):240–246 e241.
   PubMed Web of Science ®Google Scholar
• Ghaly S, Murray K, Baird A, et al. High vitamin D-binding protein concentration, low albumin, and mode of remission predict relapse in Crohn’s disease. Inflamm Bowel Dis. 2016;22(10):2456–2464.
   PubMed Web of Science ®Google Scholar
• Hanauer SB. Vitamin D levels and outcomes in inflammatory bowel disease-which is the chicken and which is the egg? Clin Gastroenterol Hepatol. 2017;15(2):247–248.
   PubMed Web of Science ®Google Scholar
• Garg M. Serum vitamin D and risk of clinical relapse in patients with ulcerative colitis. Clin Gastroenterol Hepatol. 2017;15(7):1136.
   PubMed Web of Science ®Google Scholar
• Jorgensen SP, Agnholt J, Glerup H, et al. Clinical trial: vitamin D3 treatment in Crohn’s disease - a randomized double-blind placebo-controlled study. Aliment Pharmacol Ther. 2010;32(3):377–383.
   PubMed Web of Science ®Google Scholar
• Tan B, Li P, Lv H, et al. Treatment of vitamin D deficiency in Chinese inflammatory bowel disease patients: A prospective, randomized, open-label, pilot study. J Dig Dis. 2018;19(4):215–224.
   PubMed Web of Science ®Google Scholar
• Narula N, Cooray M, Anglin R, et al. Impact of high-dose vitamin D3 supplementation in patients with Crohn’s disease in remission: a pilot randomized double-blind controlled study. Dig Dis Sci. 2017;62(2):448–455.
   PubMed Web of Science ®Google Scholar
• Li J, Chen N, Wang D, et al. Efficacy of vitamin D in treatment of inflammatory bowel disease: A meta-analysis. Medicine (Baltimore). 2018;97(46):e12662.
   PubMed Web of Science ®Google Scholar
• Nielsen OH, Rejnmark L, Moss AC. Role of vitamin D in the natural history of inflammatory Bowel disease. J Crohns Colitis. 2018;12(6):742–752.
   PubMed Web of Science ®Google Scholar
• Melamed ML, Michos ED, Post W, et al. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Internal Med. 2008;168(15):1629–1637.
   PubMed Web of Science ®Google Scholar
• Jia X, Aucott LS, McNeill G. Nutritional status and subsequent all-cause mortality in men and women aged 75 years or over living in the community. Br J Nutr. 2007;98(3):593–599.
   PubMed Web of Science ®Google Scholar
• Crockett SD, Barry EL, Mott LA, et al. Calcium and vitamin D supplementation and increased risk of serrated polyps: results from a randomised clinical trial. Gut. 2018;68:475–486.
   Web of Science ®Google Scholar